Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tianjin Pharmaceutical Da Ren Tang Group, previously known as Tianjin Zhongxin Pharmaceutical, announced the release and listing of restricted A-shares under its 2019 Restricted A-Share Incentive Scheme. This move is part of the company’s ongoing efforts to incentivize its workforce and align their interests with shareholders, potentially impacting its stock performance positively.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.